Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$2.3 - $6.29 $336,802 - $921,082
-146,436 Closed
0 $0
Q1 2022

Apr 22, 2022

SELL
$4.63 - $9.94 $326,840 - $701,684
-70,592 Reduced 32.53%
146,436 $838,000
Q4 2021

Feb 01, 2022

SELL
$8.35 - $12.6 $181,019 - $273,155
-21,679 Reduced 9.08%
217,028 $1.98 Million
Q3 2021

Nov 05, 2021

SELL
$10.13 - $15.0 $61,651 - $91,290
-6,086 Reduced 2.49%
238,707 $2.55 Million
Q2 2021

Jul 30, 2021

SELL
$13.27 - $18.48 $293,346 - $408,518
-22,106 Reduced 8.28%
244,793 $3.8 Million
Q1 2021

May 12, 2021

SELL
$14.49 - $20.72 $26.7 Million - $38.1 Million
-1,839,319 Reduced 87.33%
266,899 $4.33 Million
Q1 2021

May 04, 2021

BUY
$14.49 - $20.72 $26.7 Million - $38.1 Million
1,839,803 Added 690.58%
2,106,218 $34.1 Million
Q4 2020

Feb 03, 2021

SELL
$14.61 - $22.14 $980,126 - $1.49 Million
-67,086 Reduced 20.12%
266,415 $5.64 Million
Q3 2020

Nov 12, 2020

SELL
$13.67 - $17.77 $377,838 - $491,162
-27,640 Reduced 7.65%
333,501 $4.94 Million
Q2 2020

Aug 05, 2020

SELL
$10.89 - $21.47 $267,763 - $527,904
-24,588 Reduced 6.37%
361,141 $5.31 Million
Q1 2020

May 13, 2020

BUY
$10.23 - $24.56 $1.49 Million - $3.58 Million
145,705 Added 60.7%
385,729 $4.53 Million
Q4 2019

Feb 05, 2020

SELL
$17.42 - $26.61 $449,087 - $686,005
-25,780 Reduced 9.7%
240,024 $5.64 Million
Q3 2019

Nov 07, 2019

BUY
$16.36 - $21.39 $2.57 Million - $3.36 Million
157,309 Added 144.99%
265,804 $4.92 Million
Q2 2019

Aug 14, 2019

SELL
$16.93 - $26.22 $386,816 - $599,074
-22,848 Reduced 17.4%
108,495 $2.02 Million
Q1 2019

May 09, 2019

BUY
$23.15 - $28.34 $3.04 Million - $3.72 Million
131,343 New
131,343 $3.21 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $182M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.